Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-009110
Filing Date
2018-11-09
Accepted
2018-11-09 08:01:17
Documents
46
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q rytm-20180930x10q.htm 10-Q 1659545
2 EX-31.1 rytm-20180930ex311e92d91.htm EX-31.1 15695
3 EX-31.2 rytm-20180930ex312ebab51.htm EX-31.2 14873
4 EX-32.1 rytm-20180930ex321769347.htm EX-32.1 8424
5 EX-32.2 rytm-20180930ex3224b7e68.htm EX-32.2 8413
  Complete submission text file 0001558370-18-009110.txt   4690402

Data Files

Seq Description Document Type Size
6 EX-101.INS rytm-20180930.xml EX-101.INS 887531
7 EX-101.SCH rytm-20180930.xsd EX-101.SCH 27830
8 EX-101.CAL rytm-20180930_cal.xml EX-101.CAL 31032
9 EX-101.DEF rytm-20180930_def.xml EX-101.DEF 86129
10 EX-101.LAB rytm-20180930_lab.xml EX-101.LAB 256675
11 EX-101.PRE rytm-20180930_pre.xml EX-101.PRE 186809
Mailing Address 500 BOYLSTON STREET 11TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 11TH FLOOR BOSTON MA 02116 857-264-4280
RHYTHM PHARMACEUTICALS, INC. (Filer) CIK: 0001649904 (see all company filings)

EIN.: 462159271 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38223 | Film No.: 181171421
SIC: 2834 Pharmaceutical Preparations